Skip to main content

Table 3 Clinical features and outcome of three groups

From: Retrospective analysis of the clinical features of 172 patients with BCR-ABL1-negative chronic myeloproliferative neoplasms

IndexPMF
(n = 24)
PV
(n = 80)
ET
(n = 68)
P
Whole groupPMF vs. PVPMF vs. ETPV vs. ET
Age(year)65.5(42–78)58(21–78)57(18–77)0.122   
sex   0.180   
male174935    
female73133    
abnormal chromosome652< 0.001*0.003*0.001*0.686
JAK2 V617Fmutation157347< 0.001*0.007*0.7230.005*
Splenomegaly245823< 0.001*0.003*< 0.001*< 0.001*
Thrombosis213120.5500.5110.3420.821
hemorrhage1510.3410.5780.4560.219
Leukaemia1000.0450.2310.261/
Bone fibrosis/230.661  0.661
High LDH2456390.001*0.002*< 0.001*0.110